Author

G.-S. Liu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:CRISPR screen· 1 Research Focus:development & morphogenesis· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J. Chen· 3 shared A. B. Lyons· 2 shared A. L. Patchett· 2 shared A. S. Flies· 2 shared A. W. Hewitt· 2 shared J. M. Darby· 2 shared J.-H. Wang· 2 shared A. L. Cook· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

J. Chen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I

A. N. Kayigwe, J. M. Darby, A. B. Lyons, A. L. Patchett, L. Lisowski, G.-S. Liu, A. S. Flies

This study shows a human adenovirus encoding IFN-γ can upregulate MHC-I in Tasmanian devil tumor cells, suggesting its potential as a vaccine platform.

bioRxiv · May 29, 2022Immunology

TAK1 blockade as a therapy for retinal neovascularization

F.-L. Lin, J.-H. Wang, J. Chen, L. Zhu, Y.-F. Chuang, L. Tu, C. Ma, S. Lama, D. Ling, R. C.-B. Wong, A. W. Hewitt, C.-L. Tseng, B. V. Bui, P. van Wijngaarden, G. J. Dusting, , G.-S. Liu

This study investigates TAK1's role in retinal neovascularization and shows that inhibiting TAK1 reduces aberrant angiogenesis in a rat model.

bioRxiv · Jan 29, 2021Biochemistry

NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers

C. E. B. Ong, A. L. Patchett, J. M. Darby, J. Chen, G.-S. Liu, A. B. Lyons, G. M. Woods, A. S. Flies

This study shows NLRC5 upregulates MHC-I in transmissible cancers, making MHC-I a target for anti-tumor immunity and informing immunotherapy strategies.

bioRxiv · Sep 6, 2020Immunology

Comparison of CRISPR/Cas endonucleases for in vivo retinal gene editing.

F. Li, K. Wing, J.-H. Wang, C. D. Luu, J. A. Bender, J. Chen, Q. Wang, Q. Lu, M. T. N. T. Tran, K. M. Young, R. C. Wong, A. Pebay, A. L. Cook, S. S. Hung, G.-S. Liu, A. W. Hewitt

This study compares CRISPR/Cas endonucleases for in vivo retinal gene editing and finds SpCas9 delivered via AAV7m8 achieves the highest knockout efficacy.

bioRxiv · Jun 9, 2020Bioengineering